Castle Biosciences, Inc. (NASDAQ:CSTL)

About the company

Castle Biosciences, Inc. is a commercial-stage dermatological cancer company, which engages in the provision of genomic information for physicians and patients. The firm offers DecisionDx-Melanoma, a proprietary multi-gene expression profile (GEP) test that predicts the risk of metastasis and recurrence for patients diagnosed with invasive cutaneous melanoma. It also markets DecisionDx-UM, which is a proprietary GEP test that predicts the risk of metastasis for patients with uveal melanoma. The company was founded by Derek J. Maetzold in September 2007 and is headquartered in Friendswood, TX.

Sector

Health Services

Industry

Medical and Nursing Services

Employees

133

$61.00M

Total Revenue

133

Employees

$665.04M

Market Capitalization

652.00

Price/Earning ratio

Stock price

Gross Margin (in %)

Total gross margin

$53M

Operating Margin (in %)

Total operating margin

$9M

Net Margin (in %)

Total net margin

$6M

Dividend Yield (in %)

Dividend per share

$0

Industry peers

Name Ticker Market capitalization (in USD Million) Revenues (in USD Million) Price/Book Price/Earning Net margin (in %)
DaVita, Inc. DVA 11671.20 11487.00 5.07 12.95 7.85
Chemed Corp. CHE 7945.12 1992.00 10.85 33.41 11.60
Guardant Health, Inc. GH 7770.15 245.00 10.52 -100.66 -31.53
Amedisys, Inc. AMED 6736.62 1980.00 9.73 53.02 6.43
LHC Group, Inc. LHCG 5518.93 2091.00 3.93 56.16 4.73
1Life Healthcare, Inc. ONEM 4827.06 292.00 10.38 -60.81 -27.31
NeoGenomics, Inc. NEO 3591.28 419.00 7.37 847.00 0.82
Natera, Inc. NTRA 3509.84 330.00 14.61 -28.28 -38.27
SmileDirectClub, Inc. SDC 3118.50 769.00 9.88 -25.31 -16.02
Invitae Corp. NVTA 3045.12 241.00 12.15 -9.97 -125.90
The Ensign Group, Inc. ENSG 2376.08 2155.00 3.37 19.20 5.76
Acadia Healthcare Co., Inc. ACHC 2250.16 3130.00 0.92 19.98 3.61
MEDNAX, Inc. MD 1449.18 3508.00 1.00 -1.14 -36.30
Addus HomeCare Corp. ADUS 1289.96 598.00 3.05 62.68 3.33
U.S. Physical Therapy, Inc. USPH 1051.18 478.00 4.31 35.78 6.03
RadNet, Inc. RDNT 791.50 1164.00 6.46 395.75 0.18
Castle Biosciences, Inc. CSTL 665.04 61.00 7.72 652.00 9.75
The Pennant Group, Inc. PNTG 640.64 352.00 8.38 152.53 1.19
Option Care Health, Inc. OPCH 627.36 2539.00 2.65 -6.41 -3.63
Hanger, Inc. HNGR 612.18 1095.00 -38.36 32.88 1.71
Tivity Health, Inc. TVTY 540.00 1255.00 70.31 -1.09 -38.98
Catasys, Inc. CATS 440.13 41.00 -16.08 -14.15 -74.67
Fulgent Genetics, Inc. FLGT 324.20 35.00 4.32 -1621.00 -1.31
OptiNose, Inc. OPTN 277.35 37.00 8.38 -2.52 -295.66
American Renal Associates Holdings, Inc. ARA 205.12 824.00 -2.54 -11.45 -2.19
Aptinyx, Inc. APTX 179.64 4.00 1.86 -3.22 -810.48
Exagen, Inc. XGN 165.75 41.00 3.19 -5.18 -76.21
CRH Medical Corp. CRHM 164.62 117.00 2.17 112.75 1.52
Pro-Dex, Inc. PDEX 71.72 31.00 3.98 16.30 14.50
Guardion Health Sciences, Inc. GHSI 36.63 1.00 2.69 -1.60 -824.43
Cardiff Oncology, Inc. CRDF 30.17 0.00 12.31 -1.97 -883.77
OncoSec Medical, Inc. ONCS 25.61 None 2.10 -0.68 None
Biocept, Inc. BIOC 25.08 6.00 3.88 -0.92 -463.58
Capital Senior Living Corp. CSU 21.60 439.00 -0.69 -0.31 -16.00
American Shared Hospital Services AMS 12.66 20.00 0.46 52.75 1.28
IMAC Holdings, Inc. IMAC 10.98 16.00 1.26 -1.63 -42.30
TrovaGene, Inc. TROV 8.04 0.00 2.03 -0.48 -883.77

Latest insider transactions

Date Role Name Transaction Quantity Quantity Owned After

Hedge Funds Are Betting On Castle Biosciences, Inc. (CSTL)

7d ago, source: YAHOO!

In this article we will check out the progression of hedge fund sentiment towards Castle Biosciences, Inc. (NASDAQ:CSTL) and ...

Castle Biosciences Announces Full Exercise of Underwriters’ Option to Purchase Additional Shares of Common Stock

1d ago, source: Business Insider

Castle Biosciences, Inc. (Nasdaq: CSTL), announced today that the underwriters of its recently closed underwritten public offering of ...

Castle Biosciences Announces Pricing of $74.0 Million Public Offering of Common Stock

9d ago, source: Business Insider

Castle Biosciences, Inc. (Nasdaq: CSTL), announced today the pricing of its underwritten public offering of 2,000,000 shares of its common ...

Squarepoint Ops LLC Cuts Stock Position in Castle Biosciences (NASDAQ:CSTL)

1d ago, source: theenterpriseleader.com

Squarepoint Ops LLC cut its holdings in shares of Castle Biosciences (NASDAQ:CSTL) by 52.8% during the first quarter, ...

Castle Biosciences Announces Proposed Underwritten Public Offering of Common Stock

11d ago, source: Business Wire

FRIENDSWOOD, Texas--(BUSINESS WIRE)--Castle Biosciences, Inc. (Nasdaq: CSTL), announced today that it has commenced a proposed underwritten public offering of 1,500,000 shares of its common stock.

Castle Biosciences Announces Pricing of $74.0 Million Public Offering of Common Stock

9d ago, source: Benzinga.com

Castle Biosciences, Inc. (NASDAQ:CSTL), announced today the pricing of its underwritten public offering of 2,000,000 shares of its common stock at a price to the public of $37.00 per share.

Castle Biosciences Announces Proposed Underwritten Public Offering of Common Stock

11d ago, source: Finanzen

Castle Biosciences, Inc. (Nasdaq: CSTL), announced today that it has commenced a proposed underwritten public offering of 1,500,000 shares of its common stock. Castle Biosciences also intends to ...



Portfolio items

Follow companies to create your optimal portfolio.
or
Refresh this page to see your newly added stocks.